Federal Cannabis Rescheduling Moves the Needle Without Rewriting the Rules
The U.S. Department of Justice's April 23 announcement placing certain FDA-approved marijuana products and state-licensed medical cannabis into Schedule III of the Controlled Substances Act is real.